Dynamic Technology Lab’s BridgeBio Pharma BBIO Stock Holding History

Dynamic Technology Lab’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-15,029	Closed	-$383K	–	923
2024 Q3	$383K	Buy	+15,029	New	+$395K	0.04%	652
2024 Q2	–	Sell	-6,528	Closed	-$202K	–	953
2024 Q1	$202K	Buy	+6,528	New	+$222K	0.02%	914
2023 Q2	–	Sell	-19,106	Closed	-$317K	–	996
2023 Q1	$317K	Sell	19,106 -45,816	-71%	-$534K	0.03%	775
2022 Q4	$495K	Buy	64,922 +13,395	+26%	+$128K	0.05%	590
2022 Q3	$512K	Buy	+51,527	New	+$535K	0.05%	622
2022 Q2	–	Sell	-13,477	Closed	-$137K	–	1132
2022 Q1	$137K	Buy	+13,477	New	+$138K	0.02%	983
2021 Q4	–	Sell	-7,960	Closed	-$373K	–	1124
2021 Q3	$373K	Buy	7,960 +2,170	+37%	+$116K	0.04%	655
2021 Q2	$353K	Buy	+5,790	New	+$331K	0.04%	721

Other funds holding BBIO

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Dynamic Technology Lab's BBIO Position: Q4 2024 in Review

Dynamic Technology Lab sold out of BridgeBio Pharma (BBIO) in Q4 2024, closing a stake of 15,029 shares — an estimated $383K sold.

Dynamic Technology Lab first reported a position in BBIO in Q2 2021 and held it in 8 quarters. The position peaked at $512K in Q3 2022. 263 funds tracked by Wall St. Rank hold BBIO as of Q4 2024.

Dynamic Technology Lab reported no remaining BridgeBio Pharma position as of Q4 2024 after selling out during the quarter.
Dynamic Technology Lab sold 15,029 BridgeBio Pharma shares in Q4 2024, an estimated $383K.
Dynamic Technology Lab first reported a position in BridgeBio Pharma in Q2 2021 and held it in 8 quarters.
Dynamic Technology Lab's BridgeBio Pharma position peaked at $512K in Q3 2022.
263 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.